At a glance
ClinicalIndex Comparison RecordN/ACompleted· 175 enrolled
Drug / intervention
Spinal Cord Stimulation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vectors Post Market: A Study to Assess Pain Relief Using Spinal Cord Stimulation (SCS) With High Dose (HD) Stimulation Parameters
In Brief
A clinical study evaluating Spinal Cord Stimulation System for Chronic Pain. Completed, enrolled 175 participants across 20 sites.
Detailed Summary
This is a prospective, single-arm, multi-center study evaluating the efficacy of spinal cord stimulation (SCS) therapy for pain relief using high dose (HD) stimulation parameters delivered to neural targets identified during current commercial trial stimulation procedures. The study will evaluate changes in back and leg pain from baseline to 3, 6, and 12 months.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 2017
Enrollment StartNov 2017
Primary CompletionFeb 2019
Study CompletionOct 2019
TodayJul 2026
First PostedNov 17, 2017
Enrollment StartNov 30, 2017
Primary CompletionFeb 4, 2019
Study CompletionOct 21, 2019
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 8.6 years ago
Interventions
Spinal Cord Stimulation Systemdevice
Implanted neurostimulation system (neurostimulator and leads) with high dose stimulation parameters.